Merck Patent For Contraceptive NuvaRing Nixed As Obvious
A Delaware federal judge has ruled following a bench trial that the asserted claims of a patent that covers Merck's birth control device NuvaRing are invalid because of obviousness, handing a...To view the full article, register now.
Already a subscriber? Click here to view full article